JPWO2021242675A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021242675A5
JPWO2021242675A5 JP2022572323A JP2022572323A JPWO2021242675A5 JP WO2021242675 A5 JPWO2021242675 A5 JP WO2021242675A5 JP 2022572323 A JP2022572323 A JP 2022572323A JP 2022572323 A JP2022572323 A JP 2022572323A JP WO2021242675 A5 JPWO2021242675 A5 JP WO2021242675A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
insert
nucleic acid
expression vector
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022572323A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527791A5 (https=
JP2023527791A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033848 external-priority patent/WO2021242675A1/en
Publication of JP2023527791A publication Critical patent/JP2023527791A/ja
Publication of JP2023527791A5 publication Critical patent/JP2023527791A5/ja
Publication of JPWO2021242675A5 publication Critical patent/JPWO2021242675A5/ja
Pending legal-status Critical Current

Links

JP2022572323A 2020-05-26 2021-05-24 ウイルス性呼吸器感染症を治療するための方法 Pending JP2023527791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063030214P 2020-05-26 2020-05-26
US63/030,214 2020-05-26
PCT/US2021/033848 WO2021242675A1 (en) 2020-05-26 2021-05-24 Methods for the treatment of viral respiratory infections

Publications (3)

Publication Number Publication Date
JP2023527791A JP2023527791A (ja) 2023-06-30
JP2023527791A5 JP2023527791A5 (https=) 2024-05-22
JPWO2021242675A5 true JPWO2021242675A5 (https=) 2024-05-22

Family

ID=76859702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022572323A Pending JP2023527791A (ja) 2020-05-26 2021-05-24 ウイルス性呼吸器感染症を治療するための方法

Country Status (5)

Country Link
US (1) US20230144927A1 (https=)
EP (1) EP4158025A1 (https=)
JP (1) JP2023527791A (https=)
CN (1) CN116710118A (https=)
WO (1) WO2021242675A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022055817A1 (en) * 2020-09-09 2022-03-17 Gradalis, Inc. Composition formulated into inhalable dosage forms for the treatment of lung|tumors
US20250003010A1 (en) * 2021-11-30 2025-01-02 Gradalis, Inc. Methods for treatment response to cancers
WO2023137404A1 (en) * 2022-01-12 2023-07-20 University Of Virginia Patent Foundation Spike furin cleavage is a sars-cov-2 targeting strategy to break the chain of infection cycle
WO2023198757A1 (en) * 2022-04-14 2023-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2252275T3 (https=) 2008-02-13 2018-04-28
US9157084B2 (en) * 2009-12-23 2015-10-13 Gradalis, Inc. Furin-knockdown bi-functional RNA
CN108295087B (zh) * 2009-12-23 2021-01-15 格兰达利斯有限公司 弗林蛋白酶敲减和gm-csf增强的(fang)癌症疫苗

Similar Documents

Publication Publication Date Title
JP2026026092A5 (https=)
US20090227511A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
TW201408309A (zh) 用於治療ｂ型肝炎及ｄ型肝炎感染之方法
US20230144927A1 (en) Methods for the treatment of viral respiratory infections
CN112143731B (zh) 靶向破坏SARS-CoV-2病毒基因组的gRNA及其应用
IL266237B (en) Tolerogenic dna vaccine
CN112439058A (zh) 基于外泌体为载体的重组新型冠状病毒纳米疫苗方法
JPWO2021242675A5 (https=)
JP2005508158A5 (https=)
US20220251601A1 (en) mRNA NANOCAPSULE AND USE IN PREPARATION OF ANTIVIRAL DRUGS
WO2023109975A2 (zh) 提高基因表达的rna复制子及其应用
CN115645369B (zh) 一种肺精准靶向的脂质体纳米粒复合物及其制备方法和应用
US12274724B2 (en) Methods for treatment of cancer using chikungunya-VSV chimeric virus
TW Clarke et al. Targeted drug delivery to the virus-infected airway; complications and remedies
CN118634243B (zh) Mir2911在制备抗登革病毒denv的药物中的应用
JPWO2022010813A5 (https=)
CN118662522B (zh) Mir2911在制备抗黄热病毒yfv的药物中的应用
WO2021186042A1 (en) Plasmid comprising alopecia antigen
Deanasa et al. The potential of antisense oligonucleotides (ASO) through inhalation based on gold nanoparticle (AuNP) delivery system in inhibiting SARS-CoV-2 replication and transcription
CN121517529A (zh) 一种微肽cim53及其编码基因和应用
US20240309383A1 (en) Small interfering rna targeting hbv and uses thereof
US20230338284A1 (en) Methods for the treatment of lung tumors
Ugwoke et al. Microparticles and liposomes as pulmonary drug delivery systems: What are the recent trends
KR20240170759A (ko) 단백질 고효율 발현용 mRNA 구조체 플랫폼
CN115137835A (zh) 一种用于治疗结肠炎的rna递送系统